HighVista Strategies’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-34,760
| Closed | -$843K | – | 111 |
|
|
2022
Q1 | $843K | Buy |
34,760
+3,267
| +10% | +$79.2K | 0.54% | 53 |
|
|
2021
Q4 | $1.01M | Buy |
31,493
+2,152
| +7% | +$69.3K | 0.81% | 46 |
|
|
2021
Q3 | $1.31M | Buy |
29,341
+7,612
| +35% | +$340K | 0.87% | 28 |
|
|
2021
Q2 | $822K | Buy |
21,729
+4,142
| +24% | +$157K | 0.58% | 36 |
|
|
2021
Q1 | $651K | Buy |
+17,587
| New | +$651K | 0.48% | 49 |
|